ALLEGRI, Franca
 Distribuzione geografica
Continente #
NA - Nord America 4.135
AS - Asia 3.257
EU - Europa 2.686
SA - Sud America 386
AF - Africa 156
Continente sconosciuto - Info sul continente non disponibili 48
OC - Oceania 5
Totale 10.673
Nazione #
US - Stati Uniti d'America 4.001
SG - Singapore 1.120
CN - Cina 1.043
IT - Italia 527
VN - Vietnam 433
FI - Finlandia 396
IE - Irlanda 391
SE - Svezia 342
UA - Ucraina 308
BR - Brasile 301
DE - Germania 239
HK - Hong Kong 237
FR - Francia 158
BD - Bangladesh 125
NL - Olanda 95
ZA - Sudafrica 95
GB - Regno Unito 87
CA - Canada 85
TR - Turchia 80
CI - Costa d'Avorio 30
IN - India 29
MX - Messico 29
RU - Federazione Russa 28
AR - Argentina 27
IQ - Iraq 27
AT - Austria 22
BE - Belgio 20
EC - Ecuador 20
PL - Polonia 20
JP - Giappone 19
ID - Indonesia 17
PH - Filippine 17
PK - Pakistan 17
RO - Romania 17
KR - Corea 16
UZ - Uzbekistan 15
CO - Colombia 10
ES - Italia 9
VE - Venezuela 9
CZ - Repubblica Ceca 8
DZ - Algeria 7
KE - Kenya 7
TW - Taiwan 7
TH - Thailandia 6
AZ - Azerbaigian 5
CL - Cile 5
IL - Israele 5
IR - Iran 5
JO - Giordania 5
LT - Lituania 5
PE - Perù 5
PY - Paraguay 5
SA - Arabia Saudita 5
AU - Australia 4
CR - Costa Rica 4
MA - Marocco 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
EG - Egitto 3
HU - Ungheria 3
JM - Giamaica 3
NP - Nepal 3
RS - Serbia 3
EU - Europa 2
GT - Guatemala 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
RW - Ruanda 1
Totale 10.625
Città #
Singapore 515
San Jose 437
Dublin 391
Ashburn 388
Chandler 375
Jacksonville 319
Santa Clara 247
Hong Kong 228
Beijing 227
Dearborn 164
Nanjing 143
Boardman 137
Ho Chi Minh City 135
Council Bluffs 134
Dallas 127
Ann Arbor 111
Hanoi 104
Parma 98
Johannesburg 89
New York 84
Princeton 80
Izmir 72
Los Angeles 70
Lauterbourg 67
Shanghai 53
San Mateo 50
Jinan 49
Toronto 48
Nanchang 45
Shenyang 40
Wilmington 40
Milan 39
Hebei 36
Bremen 33
Rome 33
Des Moines 32
São Paulo 32
Abidjan 30
Munich 29
Changsha 27
Helsinki 26
Buffalo 25
Columbus 25
Kunming 25
Woodbridge 24
Seattle 23
Collecchio 22
Hefei 22
Jiaxing 21
Tianjin 21
Brussels 19
Da Nang 19
Vienna 19
Zhengzhou 19
Orem 18
Moscow 17
Frankfurt am Main 16
Guangzhou 16
Warsaw 16
Grafing 15
Haiphong 14
Montreal 14
The Dalles 14
Tashkent 13
Tokyo 13
Horia 11
Houston 11
Stockholm 11
Baghdad 10
Düsseldorf 10
Naples 10
Ningbo 10
Phoenix 10
Seoul 10
Chicago 9
Denver 9
Hangzhou 9
London 9
Turku 9
Atlanta 8
Biên Hòa 8
Boston 8
Brooklyn 8
Chengdu 8
Haikou 8
Rio de Janeiro 8
San Francisco 8
Taizhou 8
Turin 8
Amsterdam 7
Auburn Hills 7
Belo Horizonte 7
Florence 7
Jakarta 7
Nairobi 7
Norwalk 7
Quito 7
Taiyuan 7
Caracas 6
Charlotte 6
Totale 6.127
Nome #
Effect of oligomineral water with low sodium and calcium content on urinary parameters of lithogenic risk in patients with kidney stones and high urinary calcium excretion: a pilot study 295
Ipercalciuria idiopatica: confronto tra dieta ipocalcica e dieta iposodica-ipoproteica-normocalcica 287
Dieta e calcolosi renale 279
Idiopathic Calcium Nephrolithiasis and Hypovitaminosis D: a Case-Control Study 219
Idiopathic calcium nephrolithiasis and 25-OH vitamin deficiency: new scenarios ? 209
Calcium oxalate crystallization in untreated urine, centrifuged and filtered urine and ultrafiltered urine 197
Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers 197
A simple quantitative test for screening cystinuria 196
Family history influences clinical course of idiopathic calcium nephrolithiasis: case-control study of a large cohort of Italian patients 194
Indapamide therapy and hypercalciuric idiopathic calcium nephrolithiasis recurrences 191
Body weight, diet and water intake in preventing stone disease 187
Ipercalciuria idiopatica: confronto tra dieta ipocalcica e dieta iposodica-ipoproteica-normocalcica 187
Allopurinol and indapamide in recurrent calcium and nephrolithiasis with hyperuricosuria and hypercalciuria 183
Exploring the efficacy of indapamide therapy in preventing idiopathic calcium nephrolithiasis recurrence: a 25-year retrospective study 183
Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. 181
Influence of lean and fat mass on bone mineral density and on urinary stone risk factors in healthy women. 175
A diet to reduce mild hyperoxaluria in idiopathic calcium oxalate stone formers: a pilot study. 172
Come prevenire i calcoli renali 171
Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment 171
Diet to reduce mild hyperoxaluria in patients with idiopathic oxalate stone formation: a pilot study 171
Different effects of lean and fat mass on urinary stone risk factors and on bone mineral density in healthy women. 160
A diet to reduce mild hyperoxaluria in idiopathic calcium oxalate stone formers: a pilot study. 155
Hippuric acid in 24 h urine collections as a biomarker of fruits and vegetables intake in kidney stone formers 154
Insights about urinary hippuric and citric acid as biomarkers of fruit and vegetable intake in patients with kidney stones: The role of age and sex 150
Idiopathic calcium nephrolithiasis with pure calcium oxalate composition: clinical correlates of the calcium oxalate dihydrate/monohydrate (COD/COM) stone ratio 150
Aggregazione cristallina in vitro: interazione tra macromolecole urinarie e ambiente macromolecolare 147
Aggregazione cristallina in vitro: interazione tra macromolecole urinarie e ambiente macromolecolare 146
Decreased Transcriptional Activity ofCalcium-sensing receptorGene Promoter 1 Is Associated With Calcium Nephrolithiasis 146
Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria 143
Nefrolitiasi: prevenzione dell'ipercalciuria idiopatica 141
Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study 141
Low potassium diet as a stone risk factor 140
The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25 138
Copy-number disorders are a common cause of congenital kidney malformations. 137
La terapia idropinica è veramente utile nella calcolosi renale da ossalto di calcio? 133
The effect of fruits and vegetables on urinary stone risk factors 132
Vitamin D status in patients with idiopathic calcium nephrolithiasis 130
Concentrated urine and diluted urine: the effects of citrate and magnesium onthe crystallization of calcium oxalate induced in vitro by an oxalate load 127
Calcium kidney stones are associated with a haplotype of the Calcium-sensing receptor gene regulatory region. 127
Allopurinol and indapamide in recurrent calcium and nephrolithiasis with hyperuricosuria and hypercalciuria. 124
Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits 124
Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers 123
Essential arterial hypertension and stone disease 118
Nutritional aspects in primary hypercalciuria 116
Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial 113
Dietary treatment of nephrolithiasis. 111
Medical treatment of nephrolithiasis 109
Sovrasaturazione urinaria e cristallizzazione del calcio ossalato in soggetti normali e calcolotici 107
Withdrawal of sodium chloride from the table of calcium oxalate stone formers with idiopathic hypercalciuria: a three-month randomized controlled trial. 106
Urine volume: stone risk factor and preventive measure 105
Prevention of idiopathic hypercalciuria 105
Effetti della composizione corporea sulla densità ossea in donne sane e in donne con calcolosi calcica idiopatica. 104
Twenty-five years of idiopathic calcium nephrolithiasis: has anything changed? 103
Low sodium diet plus hydropinic therapy in idiopathic hypercalciuria 103
Hypercalciuria: low calcium diet in comparison with low sodium-low proteins-normal calcium diet 102
Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism 100
Una dieta per ridurre l’iperossaluria moderata in pazienti con nefrolitiasi calcica idiopatica: studio pilota 99
What is the dietary habit of women with idiopathic calcium nephrolithiasis? An italian study based on National Institute of Research for Food and Nutrition (INRAN) recommendations. 98
Effects of urine dilution on quantity, size and aggregation of calcium oxalatecrystals induced in vitro by an oxalate load. 96
Trials clinici nella nefrolitiasi: di che cosa abbiamo bisogno? Presente e futuro della ricerca clinica 94
Polymorphisms of the calcium-sensing receptor gene and stones in primary hyperparathyroidism. 94
Low potassium diet as a stone risk factor. 93
Polimorfismo genetico del calcium-sensing receptor e calcolosi renale nell’iperparatiroidismo primitivo. 91
Ruolo del BMI sui fattori di rischio litogeno in donne con nefrolitiasi calcica idiopatica e controlli. 88
Hypercalciuria: low calcium diet in comparison with low sodium -low proteins-normal calcium diet. 88
The relationship between urinary sodium and calcium excretion in women with idiopathic calcium nephrolithiasis and controls 88
Qual è l’alimentazione abituale delle donne con calcolosi calcica idiopatica? Studio italiano basato sulle linee guida INRAN. 88
The relationship between urinary sodium and calcium excretion in women with idiopathic calcium nephrolithiasis and controls 87
Role of BMI on lithogenic risk in women with idiopathic calcium nephrolithiasis and controls. 85
Evidenze scientifiche nel trattamento farmacologico della nefrolitiasi 85
Polimorfismo genetico del calcium-sensing receptor e calcolosi renale nell’iperparatiroidismo primitivo 85
Prevenzione della calcolosi renale 84
Dietary treatment nephrolitiasis 83
Dietary treatment of nephrolithiasis 83
Effects of body composition on bone density in healthy women and in women with idiopathic calcium nephrolithiasis. 83
La relazione tra escrezione di calcio e sodio urinari in donne con nefrolitiasi calcica idiopatica e controlli. 82
La relazione tra escrezione di calcio e sodio urinari in donne con nefrolitiasi calcica idiopatica e controlli 73
Ruolo del BMI sui fattori di rischio litogeno in donne con nefrolitiasi calcica idiopatica e controlli. 72
Una dieta per ridurre l’iperossaluria moderata in pazienti con nefrolitiasi calcica idiopatica: studio pilota. 71
Role of BMI on lithogenic risk in women with idiopathic calcium nephrolithiasis and controls. 68
Totale 10.673
Categoria #
all - tutte 35.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022333 0 2 2 18 3 15 49 52 14 23 25 130
2022/20231.411 138 136 87 117 114 175 5 82 501 9 26 21
2023/2024504 37 48 31 19 37 104 21 44 28 19 48 68
2024/20251.674 54 100 107 74 201 153 45 58 257 142 134 349
2025/20263.503 293 272 333 290 481 199 442 75 433 340 187 158
2026/2027424 95 329 0 0 0 0 0 0 0 0 0 0
Totale 10.673